OSCR

Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet

Overview

Authors: Huanmin Zhang1, Jinxin Kou1, Pengfei Ge2, Lingzhuan Gong3, Wen Zhang3, Yulang Fei4,5
  1. Department of Clinical Rehabilitation, School of Medicine, Xi’an Siyuan University, Xi’an, China
  2. Department of Neurology, Shiyan Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, China
  3. Department of Rehabilitation Medicine, Ordnance Industry General Hospital, Xi’an, China
  4. The First Affiliated Hospital of Nanyang Medical College, Nanyang, Henan Province, China
  5. Zhang Zhongjing Chinese Medical Research Institute, Nanyang Medical College, Nanyang, Henan Province, China
Journal: Frontiers in microbiology, volume 17, article 1884427
Dates: received 18 May 2026; accepted 14 August 2026; published online 11 September 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI · PMCID PMC13612445
Categories: genetics / omics (modality), histology / microscopy (modality), mouse (organism), Alzheimer's / dementia (population)
Methods: Statistics, Machine learning, Connectivity
Keywords: Alzheimer’s disease, cognitive impairment, gut microbiota, high-salt diet, neuronal damage
Citations: not cited yet (Europe PMC); 61 references in the paper

Abstract

Introduction: High-salt diet (HSD) has been shown to influence cognition and emotional behavior in mice via gut microbiota modulation, yet its chronic effects in Alzheimer’s disease (AD) pathology remain poorly understood. This study aimed to investigate whether long-term HSD exacerbates cognitive and emotional deficits in APP/PS1 transgenic mice and to explore the underlying gut–brain axis mechanisms involving microbiota dysbiosis, peripheral and central inflammation, hippocampal neuronal integrity, and metabolic alterations.

Methods: Six-month-old male APP/PS1 mice were randomly assigned to a normal diet (ND, 0.4% NaCl, n = 43) or high-salt diet (HSD, 8% NaCl, n = 41) for 6 months. Body weight, water intake, and blood pressure were monitored regularly (n = 10 per group). Behavioral phenotypes were assessed via open field, elevated plus maze, marble burying, light–dark box, and novel object recognition tests (n = 10). Hippocampal neuronal density was quantified by Nissl staining in CA1 and CA2, and dendritic complexity was evaluated by Golgi staining with Sholl analysis (n = 4). Gut microbiota composition was profiled by 16S rRNA sequencing (ND: n=13; HSD: n = 12), and inflammatory cytokine expression (TNF-α, IL-6, and IL-1β) in brain and liver was measured by RT-PCR and ELISA (n = 4). Hippocampal metabolomics was performed using LC–MS (ND: n = 8; HSD: n = 7). Correlation analyses integrated microbial, inflammatory, metabolic, and neuropathological data.

Results: HSD significantly altered gut microbiota structure, as shown by reduced α-diversity, distinct β-diversity (PCoA), and differential abundance of taxa including Prevotellaceae, Rikenellaceae, and Ruminococcaceae (LEfSe). Concurrently, HSD elevated pro-inflammatory cytokine expression in both brain and liver, reduced neuronal density in hippocampal CA1/CA2, and impaired dendritic arborization. Behaviorally, HSD-treated mice exhibited aggravated emotional disorders (anxiety- and compulsive-like behaviors) and worsened cognitive impairment in novelty recognition. Hippocampal metabolomics revealed substantial shifts in amino acid, energy, and neurotransmitter metabolic pathways. Spearman correlation analyses demonstrated significant interconnections among specific gut microbial genera, inflammatory markers, neuronal damage indices, and differential metabolites.

Discussion and conclusion: Long-term high-salt intake exacerbates cognitive decline and emotional disturbances in APP/PS1 mice, likely through a cascading gut–brain axis pathway: HSD-induced microbiota dysbiosis promotes peripheral and central inflammation, which in turn drives hippocampal neuronal damage and metabolic reprogramming. The strong correlations among microbial shifts, metabolic alterations, and neuropathological changes suggest that gut microbiota may serve as a critical mediator of HSD’s deleterious effects on AD-related brain functions. These findings provide new mechanistic insights into dietary risk factors in AD and highlight potential microbiota–metabolite targets for therapeutic intervention.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The data analyzed in this study are available in the NCBI SRA under accession number PRJNA1520793: https://www.ncbi.nlm.nih.gov/sra/PRJNA1520793.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 6 authors, 5 keywords, 61 references.

Cite

This paper

Zhang, H., Kou, J., Ge, P., Gong, L., Zhang, W., & Fei, Y. (2026). Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet. Frontiers in microbiology, 17, 1884427.

BibTeX

@article{zhang2026gut,
author = {Zhang, Huanmin and Kou, Jinxin and Ge, Pengfei and Gong, Lingzhuan and Zhang, Wen and Fei, Yulang},
title = {{Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet}},
journal = {Frontiers in microbiology},
year = {2026},
month = sep,
volume = {17},
pages = {1884427},
publisher = {Frontiers Media SA},
issn = {1664-302X},
pmcid = {PMC13612445}
}

RIS

TY - JOUR
AU - Zhang, Huanmin
AU - Kou, Jinxin
AU - Ge, Pengfei
AU - Gong, Lingzhuan
AU - Zhang, Wen
AU - Fei, Yulang
TI - Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet
T2 - Frontiers in microbiology
J2 - Front Microbiol
PY - 2026
DA - 2026/09/26
VL - 17
SP - 1884427
SN - 1664-302X
PB - Frontiers Media SA
LA - en
ER -

CSL-JSON

{
"id": "pmcid:PMC13612445",
"type": "article-journal",
"title": "Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet",
"container-title": "Frontiers in microbiology",
"author": [
{
"family": "Zhang",
"given": "Huanmin"
},
{
"family": "Kou",
"given": "Jinxin"
},
{
"family": "Ge",
"given": "Pengfei"
},
{
"family": "Gong",
"given": "Lingzhuan"
},
{
"family": "Zhang",
"given": "Wen"
},
{
"family": "Fei",
"given": "Yulang"
}
],
"container-title-short": "Front Microbiol",
"volume": "17",
"page": "1884427",
"PMCID": "PMC13612445",
"ISSN": "1664-302X",
"publisher": "Frontiers Media SA",
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
26
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12974-026-03796-1 [code]
Tryptophan-kynurenine metabolic reprogramming along the gut-brain axis alleviates Alzheimer's pathology.
Journal: Journal of neuroinflammation
In common: Alzheimer's / dementia, genetics / omics, mouse, 2 references
[2] doi:10.3389/fnins.2026.1849896
Dynamic changes of gut microbiota during progression of three Alzheimer's disease mice models.
Journal: Frontiers in neuroscience
In common: Alzheimer's / dementia, mouse, 2 references
[3] doi:10.1080/19490976.2022.2126272
Periodontitis-related salivary microbiota aggravates Alzheimer's disease via gut-brain axis crosstalk.
Journal: Gut microbes
In common: Alzheimer's / dementia, mouse, 2 references
[4] doi:10.1016/j.isci.2026.116622 [code]
Multi-omics profiling reveals gut microbiome signatures associated with cognitive decline in Alzheimer's disease.
Journal: iScience
In common: Alzheimer's / dementia, genetics / omics, 2 references
[5] doi:10.1186/s40364-025-00851-6 [code]
Immune, blood-brain barrier, and metabolic biomarkers mediate gut-brain axis crosstalk in alzheimer's disease.
Journal: Biomarker research
In common: Alzheimer's / dementia, genetics / omics, 2 references
[6] doi:10.3389/fphar.2026.1830927
<i>Astragalus polysaccharide</i> alleviates neuropathology and cognitive deficits by modulating gut microbiota and neuroinflammation in an Alzheimer's disease model.
Journal: Frontiers in pharmacology
In common: histology / microscopy, Alzheimer's / dementia, genetics / omics, 1 other category, 1 reference
[7] doi:10.3389/fmicb.2026.1765044
Integrating serum pharmacology, network pharmacology, and molecular biology analysis to reveal the mechanisms of Baihe Dihuang decoction in treating Alzheimer's disease.
Journal: Frontiers in microbiology
In common: histology / microscopy, Alzheimer's / dementia, genetics / omics, 1 other category, 1 reference
[8] doi:10.1128/spectrum.00178-25
<i>Clostridium butyricum</i> enhances cognitive function in APP/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota.
Journal: Microbiology spectrum
In common: histology / microscopy, Alzheimer's / dementia, mouse, 1 reference
[9] doi:10.1186/s12974-025-03480-w
OTUD1 exacerbates sepsis-associated encephalopathy by promoting HK2 mitochondrial release to drive microglia pyroptosis.
Journal: Journal of neuroinflammation
In common: histology / microscopy, genetics / omics, mouse, 1 reference
[10] doi:10.1038/s41598-025-20986-8 [code]
Fibre supplementation alters the gastrointestinal microbiome, the microbial metabolites and indicators of neurodegeneration in a mouse model of Alzheimer´s disease.
Journal: Scientific reports
In common: Alzheimer's / dementia, genetics / omics, mouse, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.